[What is the place of surgery in the management of brain metastases in 2020?]

Quelle est la place de la chirurgie dans la prise en charge des métastases cérébrales en 2020 ?
Brain metastasis Chirurgie Métastases cérébrales Overall survival Surgery Survie globale Targeted therapy Thérapie ciblée

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 15 05 2020
revised: 22 05 2020
accepted: 29 05 2020
pubmed: 11 8 2020
medline: 9 10 2020
entrez: 11 8 2020
Statut: ppublish

Résumé

Brain metastases are the most common intracranial tumors and are associated with a dismal prognosis. The management of patients with brain metastases has become more important because of the increased incidence of these tumours, the better treatment of the systemic disease and the improvement of surgical techniques. The treatment requires multidisciplinary approaches and become complex because of new emerging systemic therapy and advancements in neurosurgery and radiation oncology. The surgical treatment has an indispensable role to obtain a tissue diagnosis, in relieving intracranial effect mass and improving neurological status by improving induced encephalopathy. An understanding of the role and indications of the surgery in patients with metastatic brain lesions is essential for the effective management of this growing population.

Identifiants

pubmed: 32773281
pii: S1278-3218(20)30169-4
doi: 10.1016/j.canrad.2020.05.008
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

470-476

Informations de copyright

Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

H Cebula (H)

Service de neurochirurgie, hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France. Electronic address: helene.cebula@hotmail.fr.

J Todeschi (J)

Service de neurochirurgie, hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France.

C Le Fèvre (C)

Service de radiothérapie, institut de cancérologie Strasbourg Europe, 17, rue Albert-Calmette, 67200 Strasbourg, France.

D Antoni (D)

Service de radiothérapie, institut de cancérologie Strasbourg Europe, 17, rue Albert-Calmette, 67200 Strasbourg, France.

I Ollivier (I)

Service de neurochirurgie, hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France.

S Chibbaro (S)

Service de neurochirurgie, hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France.

G Noël (G)

Service de radiothérapie, institut de cancérologie Strasbourg Europe, 17, rue Albert-Calmette, 67200 Strasbourg, France.

F Proust (F)

Service de neurochirurgie, hôpital de Hautepierre, 1, avenue Molière, 67098 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH